Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007

Rekha Chandran, Stuart K. Gardiner, Miklos Simon, Stephen Spurgeon

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

A retrospective analysis was done using the Surveillance, Epidemiology, and End-Results (SEER) database to determine the trends in overall survival and identify prognostic factors in patients with mantle cell lymphoma (MCL). In total 5367 cases of MCL identified from 1992 to 2007 were split into three cohorts, group 1(1992-1999), group 2 (2000-2003) and group 3 (2004-2007). Survival was analyzed using the Cox proportional hazards model to correct for age, gender and stage of disease. The proportion of patients with advanced disease at diagnosis, male gender and advanced age increased over time and these were all associated with increased mortality. The overall survival remained unchanged. However, when adjusted for the increased proportion of patients with poor prognostic features noted above, we found a significant improvement in survival. The adjusted model also showed an improvement in predicted survival over time in patients with advanced stage. No change in survival was seen in patients with localized disease. Although this analysis is not designed to evaluate specific treatment modalities, these data suggest that the development of new treatment strategies over the past decade may be impacting the survival of patients with advanced MCL despite the finding that the overall survival remains unchanged in the general US population.

Original languageEnglish (US)
Pages (from-to)1488-1493
Number of pages6
JournalLeukemia and Lymphoma
Volume53
Issue number8
DOIs
StatePublished - Aug 2012

Fingerprint

Mantle-Cell Lymphoma
Survival
Proportional Hazards Models
Epidemiology
Databases
Mortality
Therapeutics

Keywords

  • Mantle cell lymphoma
  • prognostic factors
  • SEER database
  • survival trends

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007. / Chandran, Rekha; Gardiner, Stuart K.; Simon, Miklos; Spurgeon, Stephen.

In: Leukemia and Lymphoma, Vol. 53, No. 8, 08.2012, p. 1488-1493.

Research output: Contribution to journalArticle

Chandran, Rekha ; Gardiner, Stuart K. ; Simon, Miklos ; Spurgeon, Stephen. / Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007. In: Leukemia and Lymphoma. 2012 ; Vol. 53, No. 8. pp. 1488-1493.
@article{f374a7c33ef249b997498af0d8662b14,
title = "Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007",
abstract = "A retrospective analysis was done using the Surveillance, Epidemiology, and End-Results (SEER) database to determine the trends in overall survival and identify prognostic factors in patients with mantle cell lymphoma (MCL). In total 5367 cases of MCL identified from 1992 to 2007 were split into three cohorts, group 1(1992-1999), group 2 (2000-2003) and group 3 (2004-2007). Survival was analyzed using the Cox proportional hazards model to correct for age, gender and stage of disease. The proportion of patients with advanced disease at diagnosis, male gender and advanced age increased over time and these were all associated with increased mortality. The overall survival remained unchanged. However, when adjusted for the increased proportion of patients with poor prognostic features noted above, we found a significant improvement in survival. The adjusted model also showed an improvement in predicted survival over time in patients with advanced stage. No change in survival was seen in patients with localized disease. Although this analysis is not designed to evaluate specific treatment modalities, these data suggest that the development of new treatment strategies over the past decade may be impacting the survival of patients with advanced MCL despite the finding that the overall survival remains unchanged in the general US population.",
keywords = "Mantle cell lymphoma, prognostic factors, SEER database, survival trends",
author = "Rekha Chandran and Gardiner, {Stuart K.} and Miklos Simon and Stephen Spurgeon",
year = "2012",
month = "8",
doi = "10.3109/10428194.2012.656628",
language = "English (US)",
volume = "53",
pages = "1488--1493",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007

AU - Chandran, Rekha

AU - Gardiner, Stuart K.

AU - Simon, Miklos

AU - Spurgeon, Stephen

PY - 2012/8

Y1 - 2012/8

N2 - A retrospective analysis was done using the Surveillance, Epidemiology, and End-Results (SEER) database to determine the trends in overall survival and identify prognostic factors in patients with mantle cell lymphoma (MCL). In total 5367 cases of MCL identified from 1992 to 2007 were split into three cohorts, group 1(1992-1999), group 2 (2000-2003) and group 3 (2004-2007). Survival was analyzed using the Cox proportional hazards model to correct for age, gender and stage of disease. The proportion of patients with advanced disease at diagnosis, male gender and advanced age increased over time and these were all associated with increased mortality. The overall survival remained unchanged. However, when adjusted for the increased proportion of patients with poor prognostic features noted above, we found a significant improvement in survival. The adjusted model also showed an improvement in predicted survival over time in patients with advanced stage. No change in survival was seen in patients with localized disease. Although this analysis is not designed to evaluate specific treatment modalities, these data suggest that the development of new treatment strategies over the past decade may be impacting the survival of patients with advanced MCL despite the finding that the overall survival remains unchanged in the general US population.

AB - A retrospective analysis was done using the Surveillance, Epidemiology, and End-Results (SEER) database to determine the trends in overall survival and identify prognostic factors in patients with mantle cell lymphoma (MCL). In total 5367 cases of MCL identified from 1992 to 2007 were split into three cohorts, group 1(1992-1999), group 2 (2000-2003) and group 3 (2004-2007). Survival was analyzed using the Cox proportional hazards model to correct for age, gender and stage of disease. The proportion of patients with advanced disease at diagnosis, male gender and advanced age increased over time and these were all associated with increased mortality. The overall survival remained unchanged. However, when adjusted for the increased proportion of patients with poor prognostic features noted above, we found a significant improvement in survival. The adjusted model also showed an improvement in predicted survival over time in patients with advanced stage. No change in survival was seen in patients with localized disease. Although this analysis is not designed to evaluate specific treatment modalities, these data suggest that the development of new treatment strategies over the past decade may be impacting the survival of patients with advanced MCL despite the finding that the overall survival remains unchanged in the general US population.

KW - Mantle cell lymphoma

KW - prognostic factors

KW - SEER database

KW - survival trends

UR - http://www.scopus.com/inward/record.url?scp=84864229997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864229997&partnerID=8YFLogxK

U2 - 10.3109/10428194.2012.656628

DO - 10.3109/10428194.2012.656628

M3 - Article

C2 - 22242824

AN - SCOPUS:84864229997

VL - 53

SP - 1488

EP - 1493

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 8

ER -